Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


18.09.2017

1 Aliment Pharmacol Ther
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
1 Gastroenterology
6 Inflamm Bowel Dis
3 PLoS One
6 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. XU L, Lochhead P, Ko Y, Claggett B, et al
    Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis.
    Aliment Pharmacol Ther. 2017 Sep 11. doi: 10.1111/apt.14291.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. HAAS L, Chevalier R, Major BT, Enders F, et al
    Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 11. doi: 10.1007/s10620-017-4745.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results.
    Eur J Gastroenterol Hepatol. 2017 Sep 8. doi: 10.1097/MEG.0000000000000953.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  4. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Text format     Abstract available


    Gastroenterology

  5. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.
    PubMed     Text format    


    Inflamm Bowel Dis

  6. LIU X, Yu R, Zhu L, Hou X, et al
    Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:1741-1751.
    PubMed     Text format     Abstract available

  7. CROSS RK
    Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1689-1701.
    PubMed     Text format     Abstract available

  8. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1702-1709.
    PubMed     Text format     Abstract available

  9. GALLINGER ZR, Rumman A, Pivovarov K, Fortinsky KJ, et al
    Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.
    Inflamm Bowel Dis. 2017;23:1790-1795.
    PubMed     Text format     Abstract available

  10. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E50-E51.
    PubMed     Text format    

  11. RIVIERE P, Poullenot F, Zerbib F, Laharie D, et al
    Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective.
    Inflamm Bowel Dis. 2017;23:E51-E52.
    PubMed     Text format    


    PLoS One

  12. OH K, Oh EH, Baek S, Song EM, et al
    Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.
    PLoS One. 2017;12:e0179266.
    PubMed     Text format     Abstract available

  13. SHIMADA T, Nagata N, Okahara K, Joya A, et al
    PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection.
    PLoS One. 2017;12:e0184699.
    PubMed     Text format     Abstract available

  14. AL-JARALLAH A, Oriowo M
    The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis.
    PLoS One. 2017;12:e0170792.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  15. BOND A, Dodd S, Fisher G, Skouras T, et al
    Concurrent immunomodulator therapy is associated with higher adalimumab trough levels during scheduled maintenance therapy.
    Scand J Gastroenterol. 2017;52:204-208.
    PubMed     Text format     Abstract available

  16. VALERIO DE AZEVEDO S, Maltez C, Lopes AI
    Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Scand J Gastroenterol. 2017;52:29-33.
    PubMed     Text format     Abstract available

  17. BEAUPEL N, Brouquet A, Abdalla S, Carbonnel F, et al
    Preoperative oral polymeric diet enriched with transforming growth factor-beta 2 (Modulen) could decrease postoperative morbidity after surgery for complicated ileocolonic Crohn's disease.
    Scand J Gastroenterol. 2017;52:5-10.
    PubMed     Text format     Abstract available

  18. BAR-GIL SHITRIT A, Koslowsky B, Livovsky DM, Shitrit D, et al
    A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
    Scand J Gastroenterol. 2017;52:328-333.
    PubMed     Text format     Abstract available

  19. MARTI-GALLOSTRA M, Myrelid P, Mortensen N, Keshav S, et al
    The role of a defunctioning stoma for colonic and perianal Crohn's disease in the biological era.
    Scand J Gastroenterol. 2017;52:251-256.
    PubMed     Text format     Abstract available

  20. RONNBLOM A, Holmstrom T, Karlbom U, Tanghoj H, et al
    Clinical course of Crohn's disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005-2009.
    Scand J Gastroenterol. 2017;52:81-86.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: